Cargando…

Do N-terminal pro-brain natriuretic peptide levels determine the prognosis of community acquired pneumonia?

OBJECTIVE: Pneumonia is a leading cause of mortality worldwide, especially in the elderly. The use of clinical risk scores to determine prognosis is complex and therefore leads to errors in clinical practice. Pneumonia can cause increases in the levels of cardiac biomarkers such as N-terminal pro-br...

Descripción completa

Detalles Bibliográficos
Autores principales:	Akpınar, Evrim Eylem, Hoşgün, Derya, Akpınar, Serdar, Ateş, Can, Baha, Ayşe, Gülensoy, Esen Sayın, Ogan, Nalan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Pneumologia e Tisiologia 2019
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733716/ https://www.ncbi.nlm.nih.gov/pubmed/31411279 http://dx.doi.org/10.1590/1806-3713/e20180417

Ejemplares similares

Does thromboprophylaxis prevent venous thromboembolism after major orthopedic surgery?,
por: Akpinar, Evrim Eylem, et al.
Publicado: (2013)

Incidence of pulmonary embolism during COPD exacerbation,
por: Akpinar, Evrim Eylem, et al.
Publicado: (2014)

Diaphragmatic thickness in chronic obstructive lung disease and relationship with clinical severity parameters
por: OGAN, Nalan, et al.
Publicado: (2019)

A 9-year retrospective cohort of patients with lumbar disc herniation: Comparison of patient characteristics and recurrence frequency by smoking status
por: Sayin Gülensoy, Esen, et al.
Publicado: (2022)

Factors affecting 90-day mortality in community and hospital acquired pneumonia patients with or without acute kidney injury
por: Hoşgün, Derya, et al.
Publicado: (2022)

Evaluation of the factors affecting long-term mortality in geriatric patients followed up in intensive care unit due to hospital-acquired pneumonia
por: Aydemir, Semih, et al.
Publicado: (2022)

The evaluation of disease awareness, caregiver burden, and workday loss in caregivers of COPD patients
por: BAHA, Ayşe, et al.
Publicado: (2021)

N‐Terminal Pro Brain, N‐Terminal Pro Atrial Natriuretic Peptides, and Dynamic Cerebral Autoregulation
por: Mahinrad, Simin, et al.
Publicado: (2020)

The diagnostic value of n-terminal probrain natriuretic peptides to differentiate neonatal pneumoniae and transient tachypnea of the newborn
por: ARSLAN, Zeynep, et al.
Publicado: (2023)

N-terminal Pro-Brain Natriuretic Peptide And Atrial Fibrillation
por: Thejus, Jayachandran, et al.
Publicado: (2009)

Utility of point-of-care testing of natriuretic peptides (brain natriuretic peptide and n-terminal pro-brain natriuretic peptide) in the emergency department
por: Nayer, Jamshed, et al.
Publicado: (2014)

NH(2)-Terminal Pro–Brain Natriuretic Peptide and Risk of Diabetes
por: Lazo, Mariana, et al.
Publicado: (2013)

N-terminal pro brain natriuretic peptide in coronary artery disease
por: Tin, Sim Sai, et al.
Publicado: (2015)

N-Terminal Pro–B-Type Natriuretic Peptide and Incident CKD
por: Sasaki, Takaya, et al.
Publicado: (2021)

Comparison of prognostic value of N-terminal pro-brain natriuretic peptide in septic and non-septic intensive care patients
por: Ozcan, Namik, et al.
Publicado: (2017)

Artificial Intelligence-Enabled Electrocardiography Detects B-Type Natriuretic Peptide and N-Terminal Pro-Brain Natriuretic Peptide
por: Liu, Pang-Yen, et al.
Publicado: (2023)

The Importance of Amino-terminal pro-Brain Natriuretic Peptide Testing in Clinical Cardiology
por: Kimmenade, Van, et al.
Publicado: (2007)

Reply to: N-terminal pro brain natriuretic peptide in coronary artery disease
por: Radwan, Hanan, et al.
Publicado: (2015)

N‐Terminal Pro‐C‐Natriuretic Peptide and Cytokine Kinetics in Dogs with Endotoxemia
por: Floras, A.N.K., et al.
Publicado: (2014)

Levels of N-terminal pro-brain natriuretic peptide in brain injury patients
por: Tsentsiper, L, et al.
Publicado: (2015)

N-terminal Pro-B-Type Natriuretic Peptide and Malnutrition in Patients on Hemodialysis
por: Ducros, Jacques, et al.
Publicado: (2020)

N-Terminal Pro-B-Type Natriuretic Peptide and Mortality in Patients without Heart Failure Hospitalized with Severe Covid-19 Pneumonia
por: Yoo, Jeanwoo, et al.
Publicado: (2020)

N-Terminal Pro-B-type Natriuretic Peptide Levels in the Korean General Population
por: Lee, Kyung-Hoon, et al.
Publicado: (2010)

Prognostic value of amino terminal pro-b-type natriuretic peptide in septic patients
por: Maroto, Fernando, et al.
Publicado: (2008)

Amino-terminal pro-brain natriuretic peptide in children with latent rheumatic heart disease
por: Zachariah, Justin P, et al.
Publicado: (2016)

Diagnostic and prognostic values of B-type natriuretic peptides (BNP) and N-terminal fragment brain natriuretic peptides (NT-pro-BNP)
por: Maries, Lorena, et al.
Publicado: (2013)

Effects of glutamine and valsartan on the brain natriuretic peptide and N-terminal pro-B-type natriuretic peptide of patients with chronic heart failure
por: Shao, Mingliang, et al.
Publicado: (2015)

Midregional pro-atrial natriuretic peptide is a superior biomarker to N-terminal pro-B-type natriuretic peptide in the diagnosis of heart failure patients with preserved ejection fraction
por: Cui, Kun, et al.
Publicado: (2018)

Predictive value of N-terminal pro-brain natriuretic peptide among critically ill patients
por: Cubrilo-Turek, M, et al.
Publicado: (2012)

Relationship between N-terminal pro-B-type natriuretic peptide levels and metabolic syndrome
por: Bao, Yuanyuan, et al.
Publicado: (2011)

Comparison of N-Terminal Pro B-Natriuretic Peptide and Echocardiographic Indices in Patients with Mitral Regurgitation
por: Hajsadeghi, Shokoufeh, et al.
Publicado: (2010)

Perioperative application of N-terminal pro-brain natriuretic peptide in patients undergoing cardiac surgery
por: Liu, Hua, et al.
Publicado: (2013)

Plasma N-Terminal Pro B-Type Natriuretic Peptide Concentrations in Dogs with Pulmonic Stenosis
por: KOBAYASHI, Keiya, et al.
Publicado: (2014)

N-terminal pro-B-type natriuretic peptide in patients after cervical spine surgery
por: Spatenkova, V, et al.
Publicado: (2006)

Serial Measurements of N-Terminal Pro-Brain Natriuretic Peptide in Patients with Coronary Heart Disease
por: Dallmeier, Dhayana, et al.
Publicado: (2015)

Age-adjusted plasma N-terminal pro-brain natriuretic peptide level in Kawasaki disease
por: Jun, Heul, et al.
Publicado: (2016)

N-terminal-pro brain natriuretic peptides in dogs and cats: A technical and clinical review
por: de Lima, Gabriela Vieira, et al.
Publicado: (2017)

N-Terminal pro C-Type Natriuretic Peptide (NTproCNP) and myocardial function in ageing
por: Keng, Bryan M. H., et al.
Publicado: (2018)

Do N-Terminal Pro-C-Type Natriuretic Peptide Levels Relate to Severity of Preeclampsia?
por: Vatansever, Dogan, et al.
Publicado: (2020)

Association of N- terminal Pro Brain Natriuretic Peptide with Echocardiographic Measures of Diastolic Dysfunction in Cirrhosis
por: Singh, Ajmera Jail, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_cvtcbh1f9bv94t5pn9d1gennca